Prolonged response on olaparib maintenance in metastatic pancreatic acinar cell carcinoma associated with a germline BRCA 2 mutation, revealed by severe panniculitis

被引:5
|
作者
Lelong, Margaux [1 ]
Raoul, Jean-Luc [1 ]
Touchefeu, Yann [2 ]
Berthelot, Jean-Marie [3 ]
Arnolfo, Paul [3 ]
Matysiak-Budnik, Tamara [2 ]
Senellart, Helene [1 ]
机构
[1] Inst Cancerol Ouest, Dept Med Oncol, Blvd Prof Jacques MONOD, F-44805 St Herblain, France
[2] Univ Hosp, Dept Gastroenterol, IMAD, Nantes, France
[3] Univ Hosp, Dept Rhumatol, Nantes, France
来源
CLINICAL CASE REPORTS | 2022年 / 10卷 / 12期
关键词
BRCA mutation; lipase; long survival; pancreatic acinar cell cancer; panniculitis;
D O I
10.1002/ccr3.6718
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This 38-year-old man has a familial BRCA2 mutation. He presented with skin erythema, polyarthritis, dactylitis, and febrile erythema nodosum; a biopsy of a liver metastase revealed acinar cell carcinoma of the pancreas. After FOLFIRINOX, olaparib was initiated, and 24 months after, the patient was PS 0 and asymptomatic.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Pancreatic Acinar Cell Carcinoma with Germline BRCA2 Mutation and Severe Pancreatic Panniculitis: A Case Report
    Dreikhausen, Lena
    Schulte, Nadine
    Belle, Sebastian
    Weidner, Philip
    Moersdorf, Johannes
    Reissfelder, Christoph
    Ebert, Matthias P.
    Zhan, Tianzuo
    VISCERAL MEDICINE, 2021, 37 (05) : 447 - 450
  • [2] Response of germline BRCA2-mutated advanced pancreatic acinar cell carcinoma to olaparib A case report
    Li, Mao
    Mou, Yu
    Hou, Shengzhong
    Cao, Dan
    Li, Ang
    MEDICINE, 2018, 97 (45)
  • [3] Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
    Golan, Talia
    Hammel, Pascal
    Reni, Michele
    Van Cutsem, Eric
    Macarulla, Teresa
    Hall, Michael J.
    Park, Joon-Oh
    Hochhauser, Daniel
    Arnold, Dirk
    Oh, Do-Youn
    Reinacher-Schick, Anke
    Tortora, Giampaolo
    Alguel, Hana
    O'Reilly, Eileen M.
    McGuinness, David
    Cui, Karen Y.
    Schlienger, Katia
    Locker, Gershon Y.
    Kindler, Hedy L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (04): : 317 - 327
  • [4] POLO: subsequent therapy after maintenance olaparib in patients with a germline BRCA mutation and metastatic pancreatic cancer
    Arnold, D.
    Golan, T.
    Hammel, P.
    Reni, M.
    Van Cutsem, E.
    Macarulla, T.
    Hall, M. J.
    Park, J. O.
    Hochhauser, D.
    Oh, D. -Y
    Reinacher-Schick, A.
    Tortora, G.
    Alguel, H.
    O'Reilly, E. M.
    Bordia, S.
    McGuinness, D.
    Cui, K. Y.
    Kindler, H. L.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 221 - 221
  • [5] POLO: Subsequent therapy after maintenance olaparib in patients with a germline BRCA mutation and metastatic pancreatic cancer
    Golan, T.
    Hammel, P.
    Reni, M.
    Van Cutsem, E.
    Mercade, T. Macarulla
    Hall, M. J.
    Park, J. O.
    Hochhauser, D.
    Arnold, D.
    Oh, D-Y.
    Reinacher-Schick, A.
    Tortora, G.
    Algul, H.
    O'Reilly, E. M.
    Bordia, S.
    McGuinness, D.
    Cui, K. Y.
    Locker, G.
    Kindler, H.
    ANNALS OF ONCOLOGY, 2021, 32 : S1086 - S1087
  • [6] Pancreatic panniculitis associated with acinar cell pancreatic carcinoma
    Poelman, Susan M.
    Nguyen, Khue
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2008, 12 (01) : 38 - 42
  • [7] POLO: patient-centred outcomes with maintenance olaparib in patients with a germline BRCA mutation and metastatic pancreatic cancer
    Arnold, D.
    Yoo, Kyoo H.
    Kindler, H. L.
    McGuinness, D.
    Cui, K. Y.
    Joo, S.
    Golan, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 224 - 224
  • [8] POLO: Patient-Centered Outcomes With Maintenance Olaparib in PatientsWith a Germline BRCA Mutation and Metastatic Pancreatic Cancer
    Kindler, H. L.
    Yoo, H.
    McGuinness, D.
    Cui, K. Y.
    Joo, S.
    Locker, G. Y.
    Golan, T.
    PANCREAS, 2021, 50 (07) : 1071 - 1071
  • [9] POLO: Patient-centred outcomes with maintenance olaparib in patients with a germline BRCA mutation and metastatic pancreatic cancer
    Kindler, H.
    Yoo, H.
    McGuinness, D.
    Cui, K.
    Joo, S.
    Locker, G.
    Golan, T.
    ANNALS OF ONCOLOGY, 2021, 32 : S134 - S134
  • [10] The response of pancreatic acinar cell carcinoma to platinum and olaparib therapy in a germline BRCA2 variant carrier: case report and literature review
    Matsubayashi, Hiroyuki
    Todaka, Akiko
    Tsushima, Takahiro
    Kiyozumi, Yoshimi
    Harada, Rina
    Ishihara, Eiko
    Higashigawa, Satomi
    Ohike, Nobuyuki
    Sakamoto, Hiroki
    Sato, Junya
    Ishiwatari, Hirotoshi
    Sugiura, Teichi
    Uesaka, Katsuhiko
    FAMILIAL CANCER, 2024, 23 (03) : 393 - 398